Skip to main content

S 4601 — New Jersey

Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.

Passed one chamber 222 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • S 4601 is a bill in the New Jersey Senate, 222 session, introduced September 28, 2026.
  • Sponsored by Vitale, Joseph F. and Greenstein, Linda R., with 1 cosponsor.
  • Current status: passed one chamber.
  • Most recent action (October 29, 2026): Received in the Assembly, Referred to Assembly Health Committee.
  • 2 recorded votes; the most recent, on October 22, 2026, passed 39-0.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Vitale, Joseph F., Greenstein, Linda R.

Cosponsors (1): Mukherji, Raj

History

  1. Introduced, completed
  2. Passed Senate, completed
  3. Passed General Assembly, in progress
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Introduced in the Senate, Referred to Senate Commerce Committee Milestone
  2. Senate Transferred to Senate Health, Human Services and Senior Citizens Committee
  3. Senate Reported from Senate Committee with Amendments, 2nd Reading

    Reported out of Senate committee with amendments: 7 yes 0 no, 1 other Passed, 100% yes

  4. Senate Passed by the Senate (39-0) Milestone

    3RDG FINAL PASSAGE: 39 yes 0 no, 1 other Passed, 100% yes

  5. General Assembly Received in the Assembly, Referred to Assembly Health Committee Latest

Source: Open States. Last checked November 9, 2026. How we keep this accurate ›